BIOMAT Database Logo BIOMAT Database Logo

Monitoring CD4+ T cell responses against viral and tumor antigens using T cells as novel target APC. 2003

Djordje Atanackovic, and Mitsutoshi Matsuo, and Erika Ritter, and Gail Mazzara, and Gerd Ritter, and Elke Jäger, and Alexander Knuth, and Lloyd J Old, and Sacha Gnjatic
Ludwig Institute for Cancer Research, Branch at Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, Box 32, New York, NY 10021, USA.

CD4+ T cells play an important role in the induction and maintenance of an effective antiviral and antitumor immune response. However, standardized monitoring of antigen-specific CD4+ T cells has not been established at the single-cell level. We now present a sensitive, specific, and simple methodology in which purified memory CD4+ T cells are expanded from PBMC in a single cycle of antigen-driven stimulation and quantitatively assayed by interferon-gamma ELISPOT. Issues of nonspecific background in assays were resolved with the use of innovative target cells, autologous PHA-expanded CD4+ T cells (T-APC). Remarkably, T-APC could not only present peptide epitopes from model antigens NY-ESO-1 and influenza nucleoprotein, but could also process full-length antigen endogenously expressed from recombinant fowlpox vector. This approach makes it possible to monitor CD4+ T cells in large series of patients, regardless of HLA haplotype, against the full peptide repertoire of a given antigen.

UI MeSH Term Description Entries
D007118 Immunoassay A technique using antibodies for identifying or quantifying a substance. Usually the substance being studied serves as antigen both in antibody production and in measurement of antibody by the test substance. Immunochromatographic Assay,Assay, Immunochromatographic,Assays, Immunochromatographic,Immunoassays,Immunochromatographic Assays
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D002289 Carcinoma, Non-Small-Cell Lung A heterogeneous aggregate of at least three distinct histological types of lung cancer, including SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; and LARGE CELL CARCINOMA. They are dealt with collectively because of their shared treatment strategy. Carcinoma, Non-Small Cell Lung,Non-Small Cell Lung Cancer,Non-Small Cell Lung Carcinoma,Non-Small-Cell Lung Carcinoma,Nonsmall Cell Lung Cancer,Carcinoma, Non Small Cell Lung,Carcinomas, Non-Small-Cell Lung,Lung Carcinoma, Non-Small-Cell,Lung Carcinomas, Non-Small-Cell,Non Small Cell Lung Carcinoma,Non-Small-Cell Lung Carcinomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000938 Antigen-Presenting Cells A heterogeneous group of immunocompetent cells that mediate the cellular immune response by processing and presenting antigens to the T-cells. Traditional antigen-presenting cells include MACROPHAGES; DENDRITIC CELLS; LANGERHANS CELLS; and B-LYMPHOCYTES. FOLLICULAR DENDRITIC CELLS are not traditional antigen-presenting cells, but because they hold antigen on their cell surface in the form of IMMUNE COMPLEXES for B-cell recognition they are considered so by some authors. Accessory Cells, Immunologic,Antigen-Presenting Cell,Immunologic Accessory Cells,Accessory Cell, Immunologic,Cell, Immunologic Accessory,Cells, Immunologic Accessory,Immunologic Accessory Cell,Antigen Presenting Cell,Antigen Presenting Cells,Cell, Antigen-Presenting,Cells, Antigen-Presenting
D000951 Antigens, Neoplasm Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumor cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin. Neoplasm Antigens,Tumor Antigen,Tumor Antigens,Antigen, Tumor,Antigens, Tumor
D000956 Antigens, Viral Substances elaborated by viruses that have antigenic activity. Viral Antigen,Viral Antigens,Antigen, Viral

Related Publications

Djordje Atanackovic, and Mitsutoshi Matsuo, and Erika Ritter, and Gail Mazzara, and Gerd Ritter, and Elke Jäger, and Alexander Knuth, and Lloyd J Old, and Sacha Gnjatic
HLA class II-restricted CD4+ T cell responses directed against influenza viral antigens postinfluenza vaccination.
September 2003, Journal of immunology (Baltimore, Md. : 1950),
Djordje Atanackovic, and Mitsutoshi Matsuo, and Erika Ritter, and Gail Mazzara, and Gerd Ritter, and Elke Jäger, and Alexander Knuth, and Lloyd J Old, and Sacha Gnjatic
Blocking of spleen cell activity against target mammary tumor cells by viral antigens.
July 1975, Journal of immunology (Baltimore, Md. : 1950),
Djordje Atanackovic, and Mitsutoshi Matsuo, and Erika Ritter, and Gail Mazzara, and Gerd Ritter, and Elke Jäger, and Alexander Knuth, and Lloyd J Old, and Sacha Gnjatic
T-cell-dependent reactivity against tumor-associated antigens on allogeneic target cells.
March 1977, Transplantation proceedings,
Djordje Atanackovic, and Mitsutoshi Matsuo, and Erika Ritter, and Gail Mazzara, and Gerd Ritter, and Elke Jäger, and Alexander Knuth, and Lloyd J Old, and Sacha Gnjatic
The role of CD4+ T cells in tumor and chronic viral immune responses.
October 2023, MedComm,
Djordje Atanackovic, and Mitsutoshi Matsuo, and Erika Ritter, and Gail Mazzara, and Gerd Ritter, and Elke Jäger, and Alexander Knuth, and Lloyd J Old, and Sacha Gnjatic
T-cell responses against meningococcal antigens.
January 2001, Methods in molecular medicine,
Djordje Atanackovic, and Mitsutoshi Matsuo, and Erika Ritter, and Gail Mazzara, and Gerd Ritter, and Elke Jäger, and Alexander Knuth, and Lloyd J Old, and Sacha Gnjatic
Immunogenicity of human mesenchymal stem cells in HLA-class I-restricted T-cell responses against viral or tumor-associated antigens.
May 2008, Stem cells (Dayton, Ohio),
Djordje Atanackovic, and Mitsutoshi Matsuo, and Erika Ritter, and Gail Mazzara, and Gerd Ritter, and Elke Jäger, and Alexander Knuth, and Lloyd J Old, and Sacha Gnjatic
Central and effector memory CD4 and CD8 T-cell responses to tumor-associated antigens.
January 2012, Critical reviews in immunology,
Djordje Atanackovic, and Mitsutoshi Matsuo, and Erika Ritter, and Gail Mazzara, and Gerd Ritter, and Elke Jäger, and Alexander Knuth, and Lloyd J Old, and Sacha Gnjatic
Activated CD4+ T cells target mesangial antigens and initiate glomerulonephritis.
January 2012, Nephron. Experimental nephrology,
Djordje Atanackovic, and Mitsutoshi Matsuo, and Erika Ritter, and Gail Mazzara, and Gerd Ritter, and Elke Jäger, and Alexander Knuth, and Lloyd J Old, and Sacha Gnjatic
Immunological effects of tumor vaccines: II. T cell responses directed against cellular antigens in the viral oncolysates.
January 1990, In vivo (Athens, Greece),
Djordje Atanackovic, and Mitsutoshi Matsuo, and Erika Ritter, and Gail Mazzara, and Gerd Ritter, and Elke Jäger, and Alexander Knuth, and Lloyd J Old, and Sacha Gnjatic
Tumor Immunology meets…Immunology: Modified cancer cells as professional APC for priming naïve tumor-specific CD4+ T cells.
January 2017, Oncoimmunology,
Copied contents to your clipboard!